# Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

> **NCT03709134** · — · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 100 (actual)

## Conditions studied

- Breast Cancer
- Breast Neoplasms
- Cancer, Breast

## Interventions

- **DIAGNOSTIC_TEST:** Genomic Markers (CTC/ctDNA)

## Key facts

- **NCT ID:** NCT03709134
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03709134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03709134, "Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03709134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*